Virpax Pharmaceuticals Statistics
Total Valuation
VRPX has a market cap or net worth of $3.02 million. The enterprise value is $3.00 million.
| Market Cap | 3.02M |
| Enterprise Value | 3.00M |
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRPX has 4.89 million shares outstanding. The number of shares has increased by 91.15% in one year.
| Current Share Class | 4.89M |
| Shares Outstanding | 4.89M |
| Shares Change (YoY) | +91.15% |
| Shares Change (QoQ) | +135.58% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 3.28% |
| Float | 4.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -90.31 |
Financial Efficiency
Return on equity (ROE) is -594.46% and return on invested capital (ROIC) is -262.94%.
| Return on Equity (ROE) | -594.46% |
| Return on Assets (ROA) | -87.78% |
| Return on Capital (ROIC) | -262.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.89M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.19% in the last 52 weeks. The beta is 1.10, so VRPX's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -91.19% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 1.73 |
| Relative Strength Index (RSI) | 44.82 |
| Average Volume (20 Days) | 108,158 |
Short Selling Information
The latest short interest is 350,856, so 7.18% of the outstanding shares have been sold short.
| Short Interest | 350,856 |
| Short Previous Month | 565,470 |
| Short % of Shares Out | 7.18% |
| Short % of Float | 7.65% |
| Short Ratio (days to cover) | 1.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.37M |
| Pretax Income | -16.89M |
| Net Income | -13.24M |
| EBITDA | n/a |
| EBIT | -9.37M |
| Earnings Per Share (EPS) | -$5.91 |
Balance Sheet
| Cash & Cash Equivalents | 17,229 |
| Total Debt | n/a |
| Net Cash | 17,229 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | -2.05M |
| Book Value Per Share | -0.42 |
| Working Capital | -2.05M |
Cash Flow
| Operating Cash Flow | -16.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -16.85M |
| FCF Per Share | -$3.45 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRPX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -91.15% |
| Shareholder Yield | -91.15% |
| Earnings Yield | -439.01% |
| FCF Yield | -558.88% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Mar 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |